(Post-pandemic Era) - Global Radiopharmaceuticals Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Publisher Name :
Date: 21-Oct-2020
No. of pages: 97

Summary

This study analysis was given on a worldwide scale, for instance, present and historical Radiopharmaceuticals growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Radiopharmaceuticals production, Radiopharmaceuticals revenue, Radiopharmaceuticals consumption and Radiopharmaceuticals price.

According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. XYZResearch published a report for global Radiopharmaceuticals market in this environment.

In terms of revenue, this research report indicated that the global Radiopharmaceuticals market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Radiopharmaceuticals industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments.

The ????Bracco Imaging aims at producing XX Radiopharmaceuticals in 2020, with XX % production to take place in global market, ????Bayer accounts for a volume share of XX %.

At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Radiopharmaceuticals Market by XYZResearch Include

- NorthAmerica

- Asia

- Europe

- Middle East & Africa

- South America

Competitive Analysis; Who are the Major Players in Radiopharmaceuticals Market?

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Major Type of Radiopharmaceuticals Covered in XYZResearch report:

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Application Segments Covered in XYZResearch Market

- Oncology

- Cardiology

- Other

For any other requirements, please feel free to contact us and we will provide you customized report.

(Post-pandemic Era) - Global Radiopharmaceuticals Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Table of Contents

Global Radiopharmaceuticals Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Diagnostic Radioisotopes -Product Introduction and Major Manufacturers
1.1.2 Therapeutic Radioisotopes -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Radiopharmaceuticals Market Assessment by Type
3.1 Global Radiopharmaceuticals Production by Type (2015-2026)
3.2 Global Radiopharmaceuticals Revenue by Type (2015-2026)
3.3 North America Radiopharmaceuticals Production and Revenue by Type (2015-2026)
3.4 Asia Radiopharmaceuticals Production and Revenue by Type (2015-2026)
3.5 Europe Radiopharmaceuticals Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Radiopharmaceuticals Production and Revenue by Type (2015-2026)
3.7 South America Radiopharmaceuticals Production and Revenue by Type (2015-2026)
4 Global Radiopharmaceuticals Market Assessment by Application
4.1 Historical & Forecast Global Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Radiopharmaceuticals Consumption, Different Application Field (2015-2026)
5 North America
5.1 US Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Radiopharmaceuticals Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Radiopharmaceuticals Average Price Trend
10.1 Market Price for Each Type of Radiopharmaceuticals in North America (2015-2026)
10.2 Market Price for Each Type of Radiopharmaceuticals in Asia (2015-2026)
10.3 Market Price for Each Type of Radiopharmaceuticals in Europe (2015-2026)
10.4 Market Price for Each Type of Radiopharmaceuticals in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Radiopharmaceuticals in South America (2015-2026)
11 Value Chain (Impact of COVID-19)
11.1 Radiopharmaceuticals Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Radiopharmaceuticals Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Radiopharmaceuticals Competitive Analysis
12.1 Bracco Imaging
12.1.1 Bracco Imaging Company Profiles
12.1.2 Bracco Imaging Product Introduction
12.1.3 Bracco Imaging Radiopharmaceuticals Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Bayer
12.2.1 Bayer Company Profiles
12.2.2 Bayer Product Introduction
12.2.3 Bayer Radiopharmaceuticals Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Mallinckrodt
12.3.1 Mallinckrodt Company Profiles
12.3.2 Mallinckrodt Product Introduction
12.3.3 Mallinckrodt Radiopharmaceuticals Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Nordion
12.4.1 Nordion Company Profiles
12.4.2 Nordion Product Introduction
12.4.3 Nordion Radiopharmaceuticals Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 China Isotope & Radiation
12.5.1 Triad Isotopes Company Profiles
12.5.2 Triad Isotopes Product Introduction
12.5.3 Triad Isotopes Radiopharmaceuticals Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 Lantheus
12.6.1 Lantheus Company Profiles
12.6.2 Lantheus Product Introduction
12.6.3 Lantheus Radiopharmaceuticals Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 IBA Group
12.7.1 IBA Group Company Profiles
12.7.2 IBA Group Product Introduction
12.7.3 IBA Group Radiopharmaceuticals Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 GE Healthcare
12.8.1 GE Healthcare Company Profiles
12.8.2 GE Healthcare Product Introduction
12.8.3 GE Healthcare Radiopharmaceuticals Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Company Profiles
12.9.2 China Isotope & Radiation Product Introduction
12.9.3 China Isotope & Radiation Radiopharmaceuticals Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Company Profiles
12.10.2 Jubilant Pharma Product Introduction
12.10.3 Jubilant Pharma Radiopharmaceuticals Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
12.11 Eli Lilly
12.12 Advanced Accelerator Applications
12.13 SIEMENS
12.14 Dongcheng
12.15 Navidea
13 Conclusion

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Radiopharmaceuticals Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table Regional Market Share in Terms of Production (2019-2026)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure Global Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure Global Radiopharmaceuticals Production Market Share (%) by Type (2019 -2020)
Table Global Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure Global Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Radiopharmaceuticals Revenue Market Share (%) by Type (2019-2020)
Figure North America Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure North America Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure North America Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure North America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure Asia Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure Asia Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure Asia Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure Europe Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure Europe Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East & Africa Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure Middle East & Africa Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure Middle East & Africa Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Radiopharmaceuticals Production (K Unit) by Type (2015-2026)
Figure South America Radiopharmaceuticals Production (K Unit) and Growth Rate (2015-2026)
Figure South America Radiopharmaceuticals Revenue (Million USD) by Type (2015-2026)
Figure South America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2015-2026)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure North America Radiopharmaceuticals Consumption (K Unit) and Growth Rate (2015-2026)
Figure North America Radiopharmaceuticals Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure Asia Radiopharmaceuticals Consumption (K Unit) and Growth Rate (2015-2026)
Figure Asia Radiopharmaceuticals Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure Europe Radiopharmaceuticals Consumption (K Unit) and Growth Rate (2015-2026)
Figure Europe Radiopharmaceuticals Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure Middle East & Africa Radiopharmaceuticals Consumption (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Radiopharmaceuticals Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Figure South America Radiopharmaceuticals Consumption (K Unit) and Growth Rate (2015-2026)
Figure South America Radiopharmaceuticals Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Radiopharmaceuticals Different Application Field Consumption (K Unit)
Table US Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Radiopharmaceuticals Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in China
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in EU
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in USA
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Japan
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in India
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in South America
Figure Value Chain Structure of Radiopharmaceuticals
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Radiopharmaceuticals
Figure Cost Structure of Radiopharmaceuticals in 2020
Table Distributors/Traders List
Table Bracco Imaging Profiles
Table Bracco Imaging Radiopharmaceuticals Product Introduction
Figure Bracco Imaging Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bracco Imaging SWOT Analysis
Table Bayer Profiles
Table Bayer Radiopharmaceuticals Product Introduction
Figure Bayer Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bayer SWOT Analysis
Table Mallinckrodt Profiles
Table Mallinckrodt Radiopharmaceuticals Product Introduction
Figure Mallinckrodt Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Mallinckrodt SWOT Analysis
Table Nordion Profiles
Table Nordion Radiopharmaceuticals Product Introduction
Figure Nordion Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Nordion SWOT Analysis
Table Triad Isotopes Profiles
Table Triad Isotopes Radiopharmaceuticals Product Introduction
Figure Triad Isotopes Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Triad Isotopes SWOT Analysis
Table Lantheus Profiles
Table Lantheus Radiopharmaceuticals Product Introduction
Figure Lantheus Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Lantheus SWOT Analysis
Table IBA Group Profiles
Table IBA Group Radiopharmaceuticals Product Introduction
Figure IBA Group Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure IBA Group SWOT Analysis
Table GE Healthcare Profiles
Table GE Healthcare Radiopharmaceuticals Product Introduction
Figure GE Healthcare Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure GE Healthcare SWOT Analysis
Table China Isotope & Radiation Profiles
Table China Isotope & Radiation Radiopharmaceuticals Product Introduction
Figure China Isotope & Radiation Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure China Isotope & Radiation SWOT Analysis
Table Jubilant Pharma Profiles
Table Jubilant Pharma Radiopharmaceuticals Product Introduction
Figure Jubilant Pharma Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Jubilant Pharma SWOT Analysis
Table Eli Lilly Profiles
Table Eli Lilly Radiopharmaceuticals Product Introduction
Figure Eli Lilly Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Eli Lilly SWOT Analysis
Table Advanced Accelerator Applications Profiles
Table Advanced Accelerator Applications Radiopharmaceuticals Product Introduction
Figure Advanced Accelerator Applications Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Advanced Accelerator Applications SWOT Analysis
Table SIEMENS Profiles
Table SIEMENS Radiopharmaceuticals Product Introduction
Figure SIEMENS Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure SIEMENS SWOT Analysis
Table Dongcheng Profiles
Table Dongcheng Radiopharmaceuticals Product Introduction
Figure Dongcheng Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Dongcheng SWOT Analysis
Table Navidea Profiles
Table Navidea Radiopharmaceuticals Product Introduction
Figure Navidea Radiopharmaceuticals Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
  • Global Radiopharmaceutical Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......
  • Global Radiopharmaceuticals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......
  • Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137
    According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......
  • Global Radiation Dose Management Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......
  • Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......
  • Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
  • Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs